Eurofins Viracor BioPharma Expands Bioanalytical Capabilities

The company's new lab space in Lenexa, Kansas enhances support for biopharmaceutical development programs.

Published on Feb. 10, 2026

Got story updates? Submit your updates here. ›

Eurofins Viracor BioPharma, a subsidiary of Eurofins Scientific, has significantly expanded its service portfolio with the addition of enhanced bioanalytical testing capabilities at its purpose-built facility in Lenexa, Kansas. The new services are aligned with Good Laboratory Practices (GLP) and Good Clinical Practices (GCP), enabling the company to better support biopharmaceutical development programs throughout the drug development workflow.

Why it matters

The expansion underscores Eurofins Viracor BioPharma's commitment to scientific leadership and advanced quality systems, reinforcing its position as a trusted provider of specialized drug development testing solutions for pharmaceutical and contract research organizations.

The details

The bioanalytical organization brings more than two decades of specialized experience in pharmacokinetics, immunogenicity, and biomarker testing. By combining both laboratories' strengths, Eurofins Viracor BioPharma now offers a full suite of bioanalytical services, including method development, validation, and regulated sample analysis, all consistent with global regulatory guidance.

  • Eurofins Viracor BioPharma recently relocated and integrated Eurofins Pharma Bioanalytics Services from St. Charles, Missouri into its purpose-built facility in Lenexa, Kansas.

The players

Eurofins Viracor BioPharma

A subsidiary of Eurofins Scientific and a trusted provider of specialized drug development testing solutions for pharmaceutical and contract research organizations.

Eurofins Pharma Bioanalytics Services

An organization that has been integrated into Eurofins Viracor BioPharma, bringing more than two decades of specialized experience in pharmacokinetics, immunogenicity, and biomarker testing.

Got photos? Submit your photos here. ›

The takeaway

The expansion of Eurofins Viracor BioPharma's bioanalytical capabilities, including the integration of Eurofins Pharma Bioanalytics Services, strengthens the company's position as a leading provider of specialized drug development testing solutions, enabling it to better support biopharmaceutical innovators throughout the drug development process.